cytotoxin


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.

cy·to·tox·in

 (sī′tə-tŏk′sĭn)
n.
A substance having a specific toxic effect on certain cells.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

cytotoxin

(ˌsaɪtəʊˈtɒksɪn)
n
(Pathology) any substance that is poisonous to living cells
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014

cy•to•tox•in

(ˌsaɪ təˈtɒk sɪn)

n.
a substance that has a toxic effect on certain cells.
[1900–05]
cy`to•tox′ic, adj.
cy`to•tox•ic′i•ty (-tɒkˈsɪs ɪ ti) n.
Random House Kernerman Webster's College Dictionary, © 2010 K Dictionaries Ltd. Copyright 2005, 1997, 1991 by Random House, Inc. All rights reserved.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.cytotoxin - any substance that has a toxic effect on cells
toxin - a poisonous substance produced during the metabolism and growth of certain microorganisms and some higher plant and animal species
enterotoxin - a cytotoxin specific for the cells of the intestinal mucosa
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
Translations

cy·to·tox·in

n. citotoxina, agente tóxico que afecta a las células de ciertos órganos.
English-Spanish Medical Dictionary © Farlex 2012
References in periodicals archive ?
Currently, BOC Sciences' integrated capabilities for ADCs design are listed as below; meanwhile, various ready-for-use ADC linkers and ADC Cytotoxin are also available.
difficile cytotoxin to ensure enrollment of only patients with an active C.
Elzonris is a CD123-directed cytotoxin for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and in pediatric patients two years and older.
Cytotoxin assays have historically been acknowledged as the "gold standard" approach to the diagnosis of CDI.
Lumoxiti is a CD22-directed cytotoxin and is the first of this type of treatment for patients with HCL.
Lumoxiti, a CD22-directed cytotoxin, was approved for adults who have had at least two prior therapies for the disease.
The phenotypical differences in isolated HP are either related or not to the production of vacuolated cytotoxin (VacA) and cytotoxin-related protein (CagA).
The unique design of the selectively cleavable linker connecting the antibody to the duocarmycin drug leads to high stability in circulation, and induces efficient release of the cytotoxin in the tumor.
Different virulence factors which play a role in the pathogenesis of the disease have been described, such as urease enzyme, flagella, adhesins, cytotoxin-associated gene A (cagA), vacuolating cytotoxin A (vacA), and the induced by contact with epithelium (iceA) gene [3].
Up to five cytotoxins (cytotoxin 1, 2, 4, 5, and 11) have been isolated and strongly implicated in the cytotoxicity of N.